Vanguard Group Inc. Increases Holdings in Core Scientific, Inc. $CORZ

Vanguard Group Inc. increased its holdings in Core Scientific, Inc. (NASDAQ:CORZFree Report) by 5.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,600,610 shares of the company’s stock after buying an additional 1,351,395 shares during the quarter. Vanguard Group Inc. owned about 9.22% of Core Scientific worth $513,095,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CORZ. Situational Awareness LP lifted its position in Core Scientific by 76.8% during the second quarter. Situational Awareness LP now owns 7,994,038 shares of the company’s stock valued at $136,458,000 after purchasing an additional 3,472,460 shares during the period. Marshall Wace LLP grew its holdings in Core Scientific by 416.0% during the second quarter. Marshall Wace LLP now owns 3,098,737 shares of the company’s stock worth $52,895,000 after acquiring an additional 2,498,186 shares during the period. 59 North Capital Management LP acquired a new stake in Core Scientific during the second quarter worth about $35,990,000. Goodlander Investment Management LLC purchased a new position in Core Scientific during the second quarter valued at approximately $34,994,000. Finally, Westfield Capital Management Co. LP acquired a new position in Core Scientific in the second quarter valued at approximately $33,844,000.

Core Scientific Stock Up 0.9%

Shares of Core Scientific stock opened at $18.03 on Thursday. The firm has a market cap of $5.59 billion, a PE ratio of 120.23 and a beta of 6.86. Core Scientific, Inc. has a 52 week low of $6.20 and a 52 week high of $23.63. The business’s fifty day simple moving average is $17.17 and its 200-day simple moving average is $16.88.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on CORZ shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a research report on Wednesday, January 21st. Zacks Research upgraded shares of Core Scientific from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 13th. Roth Mkm reissued a “buy” rating on shares of Core Scientific in a research note on Friday, October 31st. Macquarie Infrastructure upgraded Core Scientific from a “hold” rating to an “outperform” rating and upped their price target for the company from $18.00 to $34.00 in a research report on Friday, October 31st. Finally, Citizens Jmp upgraded Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price objective on the stock in a research report on Thursday, December 18th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.47.

Check Out Our Latest Analysis on CORZ

Core Scientific Profile

(Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

Read More

Institutional Ownership by Quarter for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.